Health Technology Assessment

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review

  • Type:
    Extended Research Article Our publication formats
  • Headline:
    Study found that prostate-specific antigen velocity has prognostic value in localised prostate cancer but that further research is needed to provide stronger evidence for the most promising prognostic markers for this type of cancer
  • Authors:
    P Sutcliffe,
    S Hummel,
    E Simpson,
    T Young,
    A Rees,
    A Wilkinson,
    F Hamdy,
    N Clarke,
    J Staffurth
    Detailed Author information

    P Sutcliffe1,*, S Hummel1, E Simpson1, T Young1, A Rees1, A Wilkinson1, F Hamdy2, N Clarke3, J Staffurth4

    • 1 The University of Sheffield, School of Health and Related Research (ScHARR), UK
    • 2 Royal Hallamshire Hospital, Glossop Road, Sheffield, UK
    • 3 Manchester University, Christie Hospital and Salford Royal Hospital, Manchester, UK
    • 4 Department of Clinical Oncology, Velindre Hospital, Cardiff, UK
  • Funding:
    Health Technology Assessment programme
  • Journal:
  • Issue:
    Volume: 13, Issue: 5
  • Published:
  • Citation:
    Systematic review. Sutcliffe P, Hummel S, Simpson E, Young T, Rees A, Wilkinson A, et al. Volume 13, number 5. Published January 2009. Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review. Health Technol Assess 2009;13(5). https://doi.org/10.3310/hta13050
  • DOI:
Crossmark status check